Kinesin inhibitor, CCT251455, Purity ≥98%

Cat. No.: X24-08-YM338

Kinesin inhibitor, CCT251455, Purity ≥98%

Synonym: 1400284-80-1; CCT 251455; CCT-251455; Tert-butyl 6-[2-chloro-4-(3-methylimidazol-4-yl)anilino]-2-(1-methylpyrazol-4-yl)pyrrolo[3,2-c]pyridine-1-carboxylate

  • CAS Number: 1400284-80-1
  • Compound CID: 66547425
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
CCT251455 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting kinesin.
Molecular Weight
503.98
Molecular Formula
C26H26ClN7O2
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
CCT251455 is a cytoskeletal signaling inhibitor that can be used for its potential to disrupt mitotic spindle function and treat cancer by interfering with the mitotic process, leading to cell cycle arrest and apoptosis in cancer cells.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.